Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 5/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.74 |
| ▸ | LMNA | P02545 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.48 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.48 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zomepirac SCHEMBL11495798 | 1.00 | PTGS2 (1.00) | PTGS2ABCB11CYP1A2LMNAALDH1A1 | |
| Zomepirac SCHEMBL28350948 | 0.99 | PTGS2 (0.97) | PTGS2ABCB11CYP1A2LMNAALDH1A1 | |
| Zomepirac SCHEMBL43061 | 0.99 | PTGS2 (0.97) | PTGS2ABCB11CYP1A2LMNAALDH1A1 | |
| Zomepirac SCHEMBL9655800 | 0.99 | PTGS2 (0.97) | PTGS2ABCB11CYP1A2LMNAALDH1A1 | |
| Zomepirac SCHEMBL7204056 | 0.97 | PTGS2 (0.95) | PTGS2ABCB11CYP1A2LMNAALDH1A1 | |
| SCHEMBL12608966 | 0.89 | PTGS2 (0.80) | PTGS2ABCB11CYP1A2LMNAALDH1A1 | |
| SCHEMBL10905829 | 0.89 | PTGS2 (0.80) | PTGS2ABCB11CYP1A2LMNAALDH1A1 | |
| SCHEMBL6343780 | 0.89 | PTGS2 (0.80) | PTGS2ABCB11CYP1A2LMNAALDH1A1 | |
| Zomepirac SCHEMBL8830936 | 0.89 | PTGS2 (0.78) | PTGS2ABCB11CYP1A2LMNAALDH1A1 | |
| SCHEMBL10943158 | 0.88 | ABCB11 (0.78) | PTGS2ABCB11CYP1A2LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 20477 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130928-A1 | COMBINATION OF AKR1C3 ACTIVATED ANTICANCER PRODRUG COMPOUND AND ANALGESIC DRUG FOR TREATING CANCER PATIENTS ACCOMPANIED BY PAIN | ASCENTAWITS PHARMACEUTICALS LTD (CN) | 2026-05-14 | — | — | US | claimed |
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| EP-4628080-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DRUG-RELATED PEPTIC ULCER COMPRISING ZASTAPRAZAN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Jeil Pharmaceutical Co., Ltd. (KR) | 2025-10-08 | — | — | EP | claimed |
| EP-3917907-B1 | MODULATORS OF POTASSIUM ION CHANNELS AND USES THEREOF | UNIV DEGLI STUDI DI SALERNO (IT) | 2025-05-21 | — | — | EP | claimed |
| CN-119744178-A | Combination of AKR1C 3-activated anticancer prodrug compounds and analgesic drugs for the treatment of cancer patients with pain | 深圳艾欣达伟医药科技有限公司 | 2025-04-01 | — | — | CN | claimed |
| EP-3441087-B1 | METHODS OF TREATING CHRONIC PAIN | TEVA PHARMACEUTICALS INT GMBH (CH) | 2025-02-19 | — | — | EP | claimed |
| US-20250041208-A1 | NEW INJECTABLE COMBINATION FORMULATION | NANEXA AB (SE) | 2025-02-06 | — | — | US | claimed |
| US-12161726-B2 | Biomimetic vesicles and uses thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2024-12-10 | — | — | US | claimed |
| EP-4470565-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | OnQuality Pharmaceuticals China Ltd. (CN) | 2024-12-04 | — | — | EP | claimed |
| CN-112770764-B | Methods of treating infections using bacteria | 因达普特斯治疗有限公司 | 2024-12-03 | — | — | CN | claimed |
| US-4344929-A | Method of delivering drug with aid of effervescent activity generated in environment of use | ALZA CORPORATION (US) | 1982-08-17 | — | — | US | claimed |
| US-4338324-A | COMBINATION OF ZOMEPIRAC AND BUTORPHANOL | MCNEILAB, INC. (US) | 1982-07-06 | — | — | US | claimed |
| US-4322427-A | Analgetic compositions and methods of use | BRISTOL-MYERS COMPANY (US) | 1982-03-30 | — | — | US | claimed |
| EP-0006845-B1 | PHARMACEUTICAL COMPOSITION COMPRISING A 5-AROYL-1-C1-5 ALKYL-PYRROLE-2-ACETIC ACID COMPOUND AND ACETAMINOPHEN OR ACETYLSALICYLIC ACID | McNeilab, Inc. (US) | 1982-02-03 | — | — | EP | claimed |
| US-4299770-A | Recovery of substituted pyrrole acetate | MALLINCKRODT, INC. (US) | 1981-11-10 | — | — | US | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |
| EP-0027991-A1 | Use of combination of compounds for alleviating pain | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-05-06 | — | — | EP | claimed |
| US-4260629-A | Treating pain with acetaminophen and 1,4-dimethyl-5-p-chlorobenzoyl-pyrrole-2-acetic acid | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-04-07 | — | — | US | claimed |
| US-4132788-A | 5-AROYL-1-LOWERALKYL-PYRROLE-2-ACETIC ACID DERIVATIVES, ASPIRIN OR ACETAMINOPHEN | MCNEIL LABORATORIES, INC. (US) | 1979-01-02 | — | — | US | claimed |